Carbohydrate-based Strategies to Prevent Exercise-induced Hypoglycemia

June 8, 2020 updated by: Rémi Rabasa-Lhoret, Institut de Recherches Cliniques de Montreal

Comparison of Two Carbohydrate Intake Strategies to Improve Glucose Control During Exercise in Adolescents and Adults With Type 1 Diabetes

To prevent hypoglycemia during prolonged exercise (>30 minutes), additional carbohydrate intake is frequently required. Carbohydrate intake required will vary with insulin regimens, timing and type of exercise as well as starting blood glucose level. In addition to the amount of carbohydrate ingested, the timing of carbohydrate intake could also have an impact on glucose control during exercise. Therefore, the objective of this study will be to compare the efficacy of two snacking strategies to maintain glucose levels in the target range during an exercise period in adolescents and adults with type 1 diabetes: 1) a snack containing ~0.5g of carbohydrates per kilogram of body weight - rounded to the nearest 5g - given 5 minutes before exercise; 2) a snack containing ~0.5g of carbohydrates per kilogram of body weight - rounded to the nearest 5g - distributed this way: ~40% given 5 minutes before exercise, ~30% after 20 minutes of exercise and the last ~30% after 40 minutes of exercise.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

37

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Quebec
      • Montreal, Quebec, Canada
        • Institut de Recherches Cliniques de Montreal

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Males and females ≥ 14 years of old.
  2. Clinical diagnosis of type 1 diabetes for at least one year.
  3. Last (less than 3 months) HbA1c ≤ 10%.
  4. Patients using multiple daily injections with basal-bolus insulin regimen.

Exclusion Criteria:

  1. Clinically significant microvascular complications: nephropathy (estimated glomerular filtration rate below 40 ml/min), neuropathy (especially diagnosed gastroparesis) or severe proliferative retinopathy as judged by the investigator.
  2. Recent (< 3 months) acute macrovascular event e.g. acute coronary syndrome or cardiac surgery.
  3. Abnormal blood panel and/or anemia.
  4. Ongoing pregnancy.
  5. Severe hypoglycemic episode within two weeks of screening.
  6. Other serious medical illness likely to interfere with study participation or with the ability to complete the exercise periods by the judgment of the investigator (e.g. orthopedic limitation).
  7. Treatment with CSII (Continuous Subcutaneous Insulin Infusion) "insulin pump therapy".

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Full snack given before exercise
A snack containing ~0.5g of carbohydrates per kilogram of body weight will be given 5 minutes before exercise
Participants will be admitted at IRCM at 14:00. At 15:30, participants will performed a 60-minute exercise on the ergocycle at 60% of VO2 peak (moderate intensity). During exercise, capillary glucose levels will be measured every 10 minutes. At 16:30, the exercise will be completed and capillary glucose levels will be monitored every 20 minutes for 1 hour. At 17:30, the participant will be discharged.
Full snack or Distributed snack
Active Comparator: Distributed snack over exercise period
A snack containing ~0.5g of carbohydrates per kilogram of body weight distributed this way will be given: ~40% given 5 minutes before exercise, ~30% after 20 minutes of exercise and the last ~30% after 40 minutes of exercise.
Participants will be admitted at IRCM at 14:00. At 15:30, participants will performed a 60-minute exercise on the ergocycle at 60% of VO2 peak (moderate intensity). During exercise, capillary glucose levels will be measured every 10 minutes. At 16:30, the exercise will be completed and capillary glucose levels will be monitored every 20 minutes for 1 hour. At 17:30, the participant will be discharged.
Full snack or Distributed snack

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Percentage of time of capillary glucose levels spent between 4-10 mmol/L
Time Frame: This outcome will be measured over 120 minutes
This time frame corresponds to the exercise period and the 1 hour following it
This outcome will be measured over 120 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Percentage of time of sensor glucose levels spent between 4-10 mmol/L
Time Frame: This outcome will be measured for the exercise period only (60 minutes) and for the exercise period and the hour following the exercise (120 minutes)
This outcome will be measured for the exercise period only (60 minutes) and for the exercise period and the hour following the exercise (120 minutes)
Percentage of time of glucose levels spent below 4 mmol/L
Time Frame: This outcome will be measured for the exercise period only (60 minutes) and for the exercise period and the hour following the exercise (120 minutes)
This outcome will be measured for the exercise period only (60 minutes) and for the exercise period and the hour following the exercise (120 minutes)
Decrease in glucose levels
Time Frame: This outcome will be measured for the exercise period only (60 minutes) and for the exercise period and the hour following the exercise (120 minutes)
Difference between glucose level at the start of the exercise and the lowest glucose level from the start of the exercise until 1) the end of the exercise and 2) 1 hour after the end of the exercise.
This outcome will be measured for the exercise period only (60 minutes) and for the exercise period and the hour following the exercise (120 minutes)
Increase in glucose level
Time Frame: This outcome will be measured for the exercise period only (60 minutes) and for the exercise period and the hour following the exercise (120 minutes)
Difference between glucose level at the start of the exercise and the highest glucose level from the start of the exercise until 1) the end of the exercise and 2) 1 hour after the end of the exercise.
This outcome will be measured for the exercise period only (60 minutes) and for the exercise period and the hour following the exercise (120 minutes)
Number of participants with an exercise-induced hypoglycemia below 4 mmol/L
Time Frame: This outcome will be measured for the exercise period only (60 minutes) and for the exercise period and the hour following the exercise (120 minutes)
This outcome will be measured for the exercise period only (60 minutes) and for the exercise period and the hour following the exercise (120 minutes)
Number of participants with an exercise-induced hypoglycemia below 3.5 mmol/L
Time Frame: This outcome will be measured for the exercise period only (60 minutes) and for the exercise period and the hour following the exercise (120 minutes)
This outcome will be measured for the exercise period only (60 minutes) and for the exercise period and the hour following the exercise (120 minutes)
Number of participants requiring an oral treatment for hypoglycemia
Time Frame: This outcome will be measured for the exercise period only (60 minutes) and for the exercise period and the hour following the exercise (120 minutes)
This outcome will be measured for the exercise period only (60 minutes) and for the exercise period and the hour following the exercise (120 minutes)
Total number of hypoglycemia episodes requiring treatment
Time Frame: This outcome will be measured for the exercise period only (60 minutes) and for the exercise period and the hour following the exercise (120 minutes)
This outcome will be measured for the exercise period only (60 minutes) and for the exercise period and the hour following the exercise (120 minutes)
Percentage of time of glucose levels spent above 10 mmol/L
Time Frame: This outcome will be measured for the exercise period only (60 minutes) and for the exercise period and the hour following the exercise (120 minutes)
This outcome will be measured for the exercise period only (60 minutes) and for the exercise period and the hour following the exercise (120 minutes)
Mean time (minutes) to the first hypoglycemic event
Time Frame: This outcome will be measured for the exercise period only (60 minutes)
This outcome will be measured for the exercise period only (60 minutes)
Mean glucose levels
Time Frame: This outcome will be measured for the exercise period only (60 minutes) and for the exercise period and the hour following the exercise (120 minutes)
This outcome will be measured for the exercise period only (60 minutes) and for the exercise period and the hour following the exercise (120 minutes)
Standard deviation of glucose levels
Time Frame: This outcome will be measured for the exercise period only (60 minutes) and for the exercise period and the hour following the exercise (120 minutes)
This outcome will be measured for the exercise period only (60 minutes) and for the exercise period and the hour following the exercise (120 minutes)
Percentage of time of glucose levels between 4 and 10 mmol/L
Time Frame: From the end of the exercise period to dinner time.
Dinner time will be up to the patient.
From the end of the exercise period to dinner time.
Percentage of time of glucose levels between 4 and 10 mmol/L
Time Frame: From the end of the exercise period to midnight (7.5 hours)
From the end of the exercise period to midnight (7.5 hours)
Percentage of time of glucose levels between 4 and 10 mmol/L
Time Frame: From midnight to 6:00 next morning (6 hours)
From midnight to 6:00 next morning (6 hours)
Percentage of time of glucose levels between 4 and 10 mmol/L
Time Frame: From the end of the exercise period to 6:00 next morning (13.5 hours)
From the end of the exercise period to 6:00 next morning (13.5 hours)
Percentage of time of glucose levels spent below 4 mmol/L
Time Frame: From the end of the exercise period to dinner time
Dinner time will be up to the patient.
From the end of the exercise period to dinner time
Percentage of time of glucose levels spent below 4 mmol/L
Time Frame: From the end of the exercise period to midnight (7.5 hours)
From the end of the exercise period to midnight (7.5 hours)
Percentage of time of glucose levels spent below 4 mmol/L
Time Frame: From midnight to 6:00 next morning (6 hours)
From midnight to 6:00 next morning (6 hours)
Percentage of time of glucose levels spent below 4 mmol/L
Time Frame: From the end of the exercise period to 6:00 next morning (13.5 hours)
From the end of the exercise period to 6:00 next morning (13.5 hours)
Percentage of time of glucose levels spent above 10 mmol/L
Time Frame: From the end of the exercise period to dinner time
Dinner time will be up to the patient
From the end of the exercise period to dinner time
Percentage of time of glucose levels spent above 10 mmol/L
Time Frame: From the end of the exercise period to midnight (7.5 hours)
From the end of the exercise period to midnight (7.5 hours)
Percentage of time of glucose levels spent above 10 mmol/L
Time Frame: From midnight to 6:00 next morning (6 hours)
From midnight to 6:00 next morning (6 hours)
Percentage of time of glucose levels spent above 10 mmol/L
Time Frame: From the end of the exercise period to 6:00 next morning (13.5 hours)
From the end of the exercise period to 6:00 next morning (13.5 hours)
Number of participants requiring treatment for hypoglycemia
Time Frame: From the end of the exercise period to dinner time
Dinner time will be up to the patient
From the end of the exercise period to dinner time
Number of participants requiring treatment for hypoglycemia
Time Frame: From the end of the exercise period to midnight (7.5 hours)
From the end of the exercise period to midnight (7.5 hours)
Number of participants requiring treatment for hypoglycemia
Time Frame: From midnight to 6:00 next morning (6 hours)
From midnight to 6:00 next morning (6 hours)
Number of participants requiring treatment for hypoglycemia
Time Frame: From the end of the exercise period to 6:00 next morning (13.5 hours)
From the end of the exercise period to 6:00 next morning (13.5 hours)
Number of hypoglycemic episodes requiring treatment
Time Frame: From the end of the exercise period to dinner time
Dinner time will be up to the patient
From the end of the exercise period to dinner time
Number of hypoglycemic episodes requiring treatment
Time Frame: From the end of the exercise period to midnight (7.5 hours)
From the end of the exercise period to midnight (7.5 hours)
Number of hypoglycemic episodes requiring treatment
Time Frame: From midnight to 6:00 next morning (6 hours)
From midnight to 6:00 next morning (6 hours)
Number of hypoglycemic episodes requiring treatment
Time Frame: From the end of the exercise period to 6:00 next morning (13.5 hours)
From the end of the exercise period to 6:00 next morning (13.5 hours)
Mean glucose levels
Time Frame: From the end of the exercise period to dinner time
Dinner time will be up to the patient
From the end of the exercise period to dinner time
Mean glucose levels
Time Frame: From the end of the exercise period to midnight (7.5 hours)
From the end of the exercise period to midnight (7.5 hours)
Mean glucose levels
Time Frame: From midnight to 6:00 next morning (6 hours)
From midnight to 6:00 next morning (6 hours)
Mean glucose levels
Time Frame: From the end of the exercise period to 6:00 next morning (13.5 hours)
From the end of the exercise period to 6:00 next morning (13.5 hours)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 3, 2017

Primary Completion (Actual)

August 2, 2019

Study Completion (Actual)

August 2, 2019

Study Registration Dates

First Submitted

July 6, 2017

First Submitted That Met QC Criteria

July 10, 2017

First Posted (Actual)

July 11, 2017

Study Record Updates

Last Update Posted (Actual)

June 11, 2020

Last Update Submitted That Met QC Criteria

June 8, 2020

Last Verified

June 1, 2020

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Type 1 Diabetes Mellitus

Clinical Trials on Exercise

3
Subscribe